Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 7/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CNR1 | P21554 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | TNKS | O95271 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4456501 | 0.78 | HIF1A (0.53) | P2RX7KMT2ALMNACNR1MEN1 | |
| SCHEMBL2852998 | 0.77 | NPC1 (0.59) | P2RX7KMT2ALMNACNR1ALDH1A1 | |
| SCHEMBL15953021 | 0.76 | LIPG (0.61) | P2RX7KMT2ALMNACNR1MEN1 | |
| SCHEMBL14834496 | 0.76 | KMT2A (0.53) | P2RX7KMT2ALMNACNR1MEN1 | |
| SCHEMBL28646625 | 0.75 | CASP1 (0.57) | P2RX7KMT2ALMNACNR1MEN1 | |
| SCHEMBL31683857 | 0.75 | CASP1 (0.57) | P2RX7KMT2ALMNACNR1MEN1 | |
| SCHEMBL27081876 | 0.75 | KMT2A (0.60) | P2RX7KMT2ALMNACNR1MEN1 | |
| SCHEMBL29974694 | 0.75 | KMT2A (0.60) | P2RX7KMT2ALMNACNR1MEN1 | |
| SCHEMBL4041461 | 0.72 | KMT2A (0.63) | KMT2ALMNACNR1MEN1TRPV1 | |
| SCHEMBL13245879 | 0.72 | CNR1 (0.52) | P2RX7KMT2ACNR1MEN1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1954674-B1 | NEW N-PHENETHYLCARBOXAMIDE DERIVATIVES | BAYER IP GMBH (DE) | 2016-03-16 | — | — | EP | claimed |
| US-20090170924-A1 | N-Phenethylcarboxamide Derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2009-07-02 | — | — | US | claimed |
| EP-1954674-A1 | NEW N-PHENETHYLCARBOXAMIDE DERIVATIVES | Bayer CropScience S.A. (FR) | 2008-08-13 | — | — | EP | claimed |
| WO-2007060166-A1 | NEW N-PHENETHYLCARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2007-05-31 | — | — | WO | claimed |
| EP-1787981-A1 | New N-phenethylcarboxamide derivatives | Bayer CropScience S.A. (FR) | 2007-05-23 | — | — | EP | claimed |
| US-9440946-B2 | N-phenethylcarboxamide derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-09-13 | — | — | US | disclosed |
| EP-1954674-B1 | NEW N-PHENETHYLCARBOXAMIDE DERIVATIVES | BAYER IP GMBH (DE) | 2016-03-16 | — | — | EP | disclosed |
| US-20090170924-A1 | N-Phenethylcarboxamide Derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2009-07-02 | — | — | US | disclosed |
| EP-1954674-A1 | NEW N-PHENETHYLCARBOXAMIDE DERIVATIVES | Bayer CropScience S.A. (FR) | 2008-08-13 | — | — | EP | disclosed |
| WO-2007060166-A1 | NEW N-PHENETHYLCARBOXAMIDE DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2007-05-31 | — | — | WO | disclosed |
| EP-1787981-A1 | New N-phenethylcarboxamide derivatives | Bayer CropScience S.A. (FR) | 2007-05-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170924-A1 | N-Phenethylcarboxamide Derivatives | GANC, KCNH1, GANAB | P2RX7 542/4885KMT2A 830/4885LMNA 1170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.